{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:29Z","timestamp":1793916509985,"version":"4.8.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Perssons Stiftelse","doi-asserted-by":"publisher","award":["#FO2022-0270"],"award-info":[{"award-number":["#FO2022-0270"]}],"id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Foundation for Old Maids","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det f\u00f6r h\u00e4lsa, arbetsliv och v\u00e4lf\u00e4rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021-00694"],"award-info":[{"award-number":["JPND2021-00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2019-02397"],"award-info":[{"award-number":["2019-02397"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-02649"],"award-info":[{"award-number":["2023-02649"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-02965"],"award-info":[{"award-number":["2017-02965"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-01018"],"award-info":[{"award-number":["2022-01018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01990"],"award-info":[{"award-number":["2020-01990"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-00356"],"award-info":[{"award-number":["2023-00356"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-06105"],"award-info":[{"award-number":["2017-06105"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-06086"],"award-info":[{"award-number":["2017-06086"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2024-2027"],"award-info":[{"award-number":["2024-2027"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-4-3018"],"award-info":[{"award-number":["2020-4-3018"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer&apos;s Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","award":["2022-00732"],"award-info":[{"award-number":["2022-00732"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021790","name":"Fondation pour la Recherche sur Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun and Bertil Stohnes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["ZEN-21-848495"],"award-info":[{"award-number":["ZEN-21-848495"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["SG-23-1038904 QC"],"award-info":[{"award-number":["SG-23-1038904 QC"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","award":["RB13-0192"],"award-info":[{"award-number":["RB13-0192"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007505","name":"Kirsten og Freddy Johansens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ebiom.2024.105504","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:38:38Z","timestamp":1734547118000},"page":"105504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4275-8719","authenticated-orcid":false,"given":"Marina","family":"Bluma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Chiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savitcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Matton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Kivipelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jeromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5339-933X","authenticated-orcid":false,"given":"Guglielmo","family":"Di Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-5151","authenticated-orcid":false,"given":"Agneta","family":"Nordberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105504_bib3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp-2022-330619","article-title":"Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic","volume":"94","author":"Altomare","year":"2023","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105504_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib6","first-page":"1","article-title":"Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia","volume":"14","author":"Thijssen","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105504_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105504_bib8","first-page":"1","article-title":"The accuracy and robustness of plasma biomarker models for amyloid PET positivity","volume":"0","author":"Benedet","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/brain\/awac399","article-title":"Plasma biomarker profiles in autosomal dominant Alzheimer\u2019 s disease","volume":"146","author":"Johansson","year":"2023","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105504_bib10","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau 231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105504_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib13","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00414-021-02568-1","article-title":"GFAP positivity in neurons following traumatic brain injuries","volume":"135","author":"Zwirner","year":"2021","journal-title":"Int J Legal Med"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105504_bib14","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41386-022-01359-5","article-title":"Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury","volume":"47","author":"Kulbe","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ebiom.2024.105504_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3389\/fneur.2020.01054","article-title":"Comparing glial fibrillary acidic protein (GFAP) in serum and plasma following mild traumatic brain injury in older adults","volume":"11","author":"Huebschmann","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13049-022-01065-7","article-title":"Diagnostic performance of glial fibrillary acidic protein and prehospital stroke scale for identification of stroke and stroke subtypes in an unselected patient cohort with symptom onset < 4.5 h","volume":"31","author":"J\u00e6ger","year":"2023","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105504_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/23969873211010069","article-title":"Serum GFAP for stroke diagnosis in regions with limited access to brain imaging (BE FAST India)","volume":"6","author":"Kalra","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.ebiom.2024.105504_bib18","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.2147\/JIR.S342097","article-title":"Glial fibrillary acidic protein (GFAP): neuroinflammation biomarker in acute ischemic stroke","volume":"14","author":"Amalia","year":"2021","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.ebiom.2024.105504_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2024.105504_bib20","first-page":"1","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer's disease","volume":"2021","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2024.105504_bib21","series-title":"Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer\u2019s disease: associations with \u03b2 - amyloid-PET, Neurodegeneration and cognition","author":"Chatterjee","year":"2022"},{"key":"10.1016\/j.ebiom.2024.105504_bib22","first-page":"1","article-title":"Diagnostic and prognostic performance to detect Alzheimer\u2019s disease and clinical progression of a novel assay for plasma p-tau217","volume":"14","author":"Groot","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer's disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2024.105504_bib25","series-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer","year":"2022"},{"key":"10.1016\/j.ebiom.2024.105504_bib26","first-page":"1","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads","volume":"46","author":"Salvad\u00f3","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ebiom.2024.105504_bib27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awae104","article-title":"Blood GFAP reflects astrocyte reactivity to Alzheimer's pathology in post-mortem brain tissue","volume":"147","author":"S\u00e1nchez-Juan","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib28","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-020-01019-z","article-title":"Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain","volume":"8","author":"Horie","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105504_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/d41573-023-00083-z","article-title":"NfL makes regulatory debut as neurodegenerative disease biomarker","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23620-z","article-title":"A\u00a0multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105504_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105504_bib34","series-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","author":"Palmqvist","year":"2015"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s13760-019-01112-8","article-title":"CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort","volume":"119","author":"Spallazzi","year":"2019","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ebiom.2024.105504_bib37","series-title":"Personality disorder, severity unspecified. Encyclopedia of personality and individual differences","first-page":"3798","year":"2020"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"FTD A consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"issue":"February","key":"10.1016\/j.ebiom.2024.105504_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01233-3","article-title":"Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study","volume":"9","author":"Iida","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ebiom.2024.105504_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B","article-title":"Alcohol related dementia (ARD)","author":"Oslin","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib44","first-page":"1","article-title":"Effects of pre-analytical procedures on blood biomarkers for alzheimer's pathophysiology, glial activation, and neurodegeneration","volume":"13","author":"Ashton","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105504_bib45","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2024.105504_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118775","article-title":"rPOP: robust PET-only processing of community acquired heterogeneous amyloid-PET data","volume":"246","author":"Iaccarino","year":"2022","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105504_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13550-018-0456-7","article-title":"Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods","volume":"8","author":"Battle","year":"2018","journal-title":"EJNMMI Res"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105504_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u2018probable\u2019 Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105504_bib50","first-page":"268","article-title":"Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts","volume":"36","author":"Pasquier","year":"1996","journal-title":"Eur Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105504_bib51","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1007\/s00330-016-4726-3","article-title":"Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: validation in a large memory clinic population","volume":"27","author":"Claus","year":"2017","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12358","article-title":"Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment","volume":"278","author":"Ferreira","year":"2015","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ebiom.2024.105504_bib53","series-title":"eBook","first-page":"441","article-title":"An introduction to statistical learning: with applications in R. 8","author":"James","year":"2017"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105504_bib54","first-page":"1071","article-title":"Editorial: what are the remaining challenges before blood-based biomarkers for Alzheimer's disease can be used in clinical practice?","volume":"18","author":"Bittner","year":"2022","journal-title":"J\u00a0Prev Alzheimers Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105504_bib55","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.ajpath.2017.03.011","article-title":"Enhanced tau aggregation in the presence of amyloid \u03b2","volume":"187","author":"Bennett","year":"2017","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105504_bib56","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A\u00a0soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nat Med"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105504_bib57","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid \u03b2-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105504_bib58","doi-asserted-by":"crossref","first-page":"695479","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood\u2013brain barrier dysfunction in alzheimer's disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib59","first-page":"1","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"S24","key":"10.1016\/j.ebiom.2024.105504_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/alz.083173","article-title":"Independent associations of plasma GFAP with amyloid-\u03b2 and tau in Alzheimer's disease","volume":"19","author":"Jia","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105504_bib62","doi-asserted-by":"crossref","first-page":"e1385","DOI":"10.1212\/WNL.0000000000006321","article-title":"Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI","volume":"91","author":"Gill","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105504_bib63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fncel.2018.00366","article-title":"Plasma markers of neurodegeneration are raised in friedreich's ataxia","volume":"12","author":"Zeitlberger","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib64","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105504_bib65","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105504_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105504_bib67","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105504_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-tau217 levels with tau positron emission tomography in early alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the\u00a0association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s43587-023-00405-1","article-title":"Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies","volume":"3","author":"Montoliu-Gaya","year":"2023","journal-title":"Nat Aging"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105504_bib71","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1002\/alz.12986","article-title":"Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort","volume":"19","author":"Ferreira","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib72","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer's disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat Aging"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105504_bib73","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1212\/WNL.0000000000010084","article-title":"NfL as a biomarker for neurodegeneration and survival in Parkinson disease","volume":"95","author":"B\u00e4ckstr\u00f6m","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105504_bib74","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0211575","article-title":"Plasma neurofilament light chain: a potential prognostic biomarker of dementia in adult down syndrome patients","volume":"14","author":"Shinomoto","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105504_bib77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2020.09.008","article-title":"The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's disease","volume":"97","author":"Walsh","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105504_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.16278","article-title":"Association of serum neurofilament light levels with long-term brain atrophy in patients with a first multiple sclerosis episode","volume":"3","author":"Plavina","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41398-023-02558-4","article-title":"Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic","volume":"13","author":"Bucci","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105504_bib80","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","article-title":"Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI","volume":"122","author":"Toledo","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ebiom.2024.105504_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40035-023-00371-z","article-title":"The potential impact of clinical factors on blood-based biomarkers for Alzheimer's disease","volume":"12","author":"Pan","year":"2023","journal-title":"Transl Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52387","article-title":"Association of kidney function with development of alzheimer disease and other dementias and dementia-related blood biomarkers","volume":"6","author":"Stocker","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105504_bib85","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ebiom.2024.105504_bib86","article-title":"Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer's disease","volume":"15","author":"Zhang","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2024.105504_bib87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2023.4719","article-title":"Effect of neprilysin inhibition on Alzheimer disease plasma biomarkers","volume":"81","author":"Brum","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2024.105504_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2023.04.011","article-title":"The association between personality and plasma biomarkers of astrogliosis and neuronal injury","volume":"128","author":"Terracciano","year":"2023","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105504_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:37:24Z","timestamp":1778873844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424005401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":89,"alternative-id":["S2352396424005401"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105504","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinics","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105504"}}